IL-24: Physiological and supraphysiological effects on normal and malignant cells

Current Medicinal Chemistry

Volumn 17, Issue 29, 2010, Pages 3318-3326

  Margue, C ^a   Kreis, S ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

Adenovirus; Cancer; Cytokine; IL 24; Inflammation; Skin disease

Indexed keywords

ADENOVIRUS VECTOR; INGN 241; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 24 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; RECEPTOR; RECOMBINANT INTERLEUKIN 24; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL PROLIFERATION; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; EPIDERMIS; HUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 77957943188     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710793176311     Document Type: Article

References (82)

1. Emdad, L.; Lebedeva, I.V.; Su, Z.Z.; Gupta, P.; Sauane, M.; Dash, R.; Grant, S.; Dent, P.; Curiel, D.T.; Sarkar, D.; Fisher, P.B. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biol. Ther., 2009, 8(5), 391-400.
2. Jiang, H.; Lin, J.J.; Su, Z.Z.; Goldstein, N.I.; Fisher, P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene, 1995, 11(12), 2477-2486.
3. Zhang, R.; Tan, Z.; Liang, P. Identification of a novel ligandreceptor pair constitutively activated by ras oncogenes. J. Biol. Chem., 2000, 275(32), 24436-24443.
4. Dumoutier, L.; Leemans, C.; Lejeune, D.; Kotenko, S.V.; Renauld, J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol., 2001, 167(7), 3545-3549.
5. Parrish-Novak, J.; Xu, W.; Brender, T.; Yao, L.; Jones, C.; West, J.; Brandt, C.; Jelinek, L.; Madden, K.; McKernan, P.A.; Foster, D.C.; Jaspers, S.; Chandrasekher, Y.A. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J. Biol. Chem., 2002, 277(49), 47517-47523.
6. Wang, M.; Tan, Z.; Zhang, R.; Kotenko, S.V.; Liang, P. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J. Biol. Chem., 2002, 277(9), 7341-7347.
7. Cunningham, C.C.; Chada, S.; Merritt, J.A.; Tong, A.; Senzer, N.; Zhang, Y.; Mhashilkar, A.; Parker, K.; Vukelja, S.; Richards, D.; Hood, J.; Coffee, K.; Nemunaitis, J. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol. Ther., 2005, 11(1), 149-159.
8. Tong, A.W.; Nemunaitis, J.; Su, D.; Zhang, Y.; Cunningham, C.; Senzer, N.; Netto, G.; Rich, D.; Mhashilkar, A.; Parker, K.; Coffee, K.; Ramesh, R.; Ekmekcioglu, S.; Grimm, E.A.; van Wart Hood, J.; Merritt, J.; Chada, S. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol. Ther., 2005, 11(1), 160-172.
9. Lebedeva, I.V.; Emdad, L.; Su, Z.Z.; Gupta, P.; Sauane, M.; Sarkar, D.; Staudt, M.R.; Liu, S.J.; Taher, M.M.; Xiao, R.; Barral, P.; Lee, S.G.; Wang, D.; Vozhilla, N.; Park, E.S.; Chatman, L.; Boukerche, H.; Ramesh, R.; Inoue, S.; Chada, S.; Li, R.; De Pass, A.L.; Mahasreshti, P.J.; Dmitriev, I.P.; Curiel, D.T.; Yacoub, A.; Grant, S.; Dent, P.; Senzer, N.; Nemunaitis, J.J.; Fisher, P.B. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int. J. Oncol., 2007, 31(5), 985-1007.
10. Ramesh, R.; Mhashilkar, A.M.; Tanaka, F.; Saito, Y.; Branch, C.D.; Sieger, K.; Mumm, J.B.; Stewart, A.L.; Boquoi, A.; Dumoutier, L.; Grimm, E.A.; Renauld, J.C.; Kotenko, S.; Chada, S. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res., 2003, 63(16), 5105-5113.
11. Su, Z.; Emdad, L.; Sauane, M.; Lebedeva, I.V.; Sarkar, D.; Gupta, P.; James, C.D.; Randolph, A.; Valerie, K.; Walter, M.R.; Dent, P.; Fisher, P.B. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene, 2005, 24 7552-7566.
12. Chada, S.; Mhashilkar, A.M.; Ramesh, R.; Mumm, J.B.; Sutton, R.B.; Bocangel, D.; Zheng, M.; Grimm, E.A.; Ekmekcioglu, S. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism. Mol. Ther., 2004, 10(6), 1085-1095.
13. Edelstein, M.L.; Abedi, M.R.; Wixon, J. Gene therapy clinical trials worldwide to 2007--an update. J. Gene Med., 2007, 9(10), 833-842.
14. Raper, S.E.; Chirmule, N.; Lee, F.S.; Wivel, N.A.; Bagg, A.; Gao, G.P.; Wilson, J.M.; Batshaw, M.L. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab., 2003, 80(1-2), 148-158.
15. Bangari, D.S.; Mittal, S.K. Current strategies and future directions for eluding adenoviral vector immunity. Curr. Gene. Ther., 2006, 6(2), 215-226.
16. Sakurai, H.; Kawabata, K.; Sakurai, F.; Nakagawa, S.; Mizuguchi, H. Innate immune response induced by gene delivery vectors. Int. J. Pharm., 2008, 354(1-2), 9-15.
17. Tahara, I.; Miyake, K.; Hanawa, H.; Kurai, T.; Hirai, Y.; Ishizaki, M.; Uchida, E.; Tajiri, T.; Shimada, T. Systemic cancer gene therapy using adeno-associated virus type 1 vector expressing MDA-7/IL24. Mol. Ther., 2007, 15(10), 1805-1811.
18. Eager, R.; Harle, L.; Nemunaitis, J. Ad-MDA-7; INGN 241: a review of preclinical and clinical experience. Expert Opin. Biol. Ther., 2008, 8(10), 1633-1643.
19. Sauane, M.; Gopalkrishnan, R.V.; Choo, H.T.; Gupta, P.; Lebedeva, I.V.; Yacoub, A.; Dent, P.; Fisher, P.B. Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein. Oncogene, 2004, 23(46), 7679-7690.
20. Yacoub, A.; Gupta, P.; Park, M.A.; Rhamani, M.; Hamed, H.; Hanna, D.; Zhang, G.; Sarkar, D.; Lebedeva, I.V.; Emdad, L.; Koumenis, C.; Curiel, D.T.; Grant, S.; Fisher, P.B.; Dent, P. Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling. Mol. Cancer Ther., 2008, 7(2), 314-329.
21. Dong, C.Y.; Zhang, F.; Duan, Y.J.; Yang, B.X.; Lin, Y.M.; Ma, X.T. mda-7/IL-24 inhibits the proliferation of hematopoietic malignancies in vitro and in vivo. Exp. Hematol., 2008, 36(8), 938-946.
22. Kreis, S.; Philippidou, D.; Margue, C.; Rolvering, C.; Haan, C.; Dumoutier, L.; Renauld, J.C.; Behrmann, I. Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells. PLoS One, 2007, 2(12), e1300.
23. Sieger, K.A.; Mhashilkar, A.M.; Stewart, A.; Sutton, R.B.; Strube, R.W.; Chen, S.Y.; Pataer, A.; Swisher, S.G.; Grimm, E.A.; Ramesh, R.; Chada, S. The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells. Mol. Ther., 2004, 9(3), 355-367.
24. Healy, S.J.; Gorman, A.M.; Mousavi-Shafaei, P.; Gupta, S.; Samali, A. Targeting the endoplasmic reticulum-stress response as an anticancer strategy. Eur. J. Pharmacol., 2009, 625(1-3), 234-246.
25. Gupta, P.; Walter, M.R.; Su, Z.Z.; Lebedeva, I.V.; Emdad, L.; Randolph, A.; Valerie, K.; Sarkar, D.; Fisher, P.B. BiP/GRP78 Is an Intracellular Target for MDA-7/IL-24 Induction of Cancer-Specific Apoptosis. Cancer Res., 2006, 66(16), 8182-8191.
26. Vandenbroeck, K.; Alloza, I.; Brehmer, D.; Billiau, A.; Proost, P.; McFerran, N.; Rudiger, S.; Walker, B. The conserved helix C region in the superfamily of interferon-gamma /interleukin-10-related cytokines corresponds to a high-affinity binding site for the HSP70 chaperone DnaK. J. Biol. Chem., 2002, 277(28), 25668-25676.
27. Pataer, A.; Vorburger, S.A.; Barber, G.N.; Chada, S.; Mhashilkar, A.M.; Zou-Yang, H.; Stewart, A.L.; Balachandran, S.; Roth, J.A.; Hunt, K.K.; Swisher, S.G. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNAdependent protein kinase (PKR). Cancer Res., 2002, 62(8), 2239-2243.
28. Sarkar, D.; Su, Z.Z.; Lebedeva, I.V.; Sauane, M.; Gopalkrishnan, R.V.; Valerie, K.; Dent, P.; Fisher, P.B. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Natl. Acad. Sci. U.S.A., 2002, 99(15), 10054-10059.
29. Lebedeva, I.V.; Su, Z.Z.; Sarkar, D.; Kitada, S.; Dent, P.; Waxman, S.; Reed, J.C.; Fisher, P.B. Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res., 2003, 63(23), 8138-8144.
30. Lebedeva, I.V.; Su, Z.Z.; Sarkar, D.; Gopalkrishnan, R.V.; Waxman, S.; Yacoub, A.; Dent, P.; Fisher, P.B. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. Oncogene, 2005, 24(4), 585-596.
31. Mhashilkar, A.M.; Stewart, A.L.; Sieger, K.; Yang, H.Y.; Khimani, A.H.; Ito, I.; Saito, Y.; Hunt, K.K.; Grimm, E.A.; Roth, J.A.; Meyn, R.E.; Ramesh, R.; Chada, S. MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol. Ther., 2003, 8(2), 207-219.
32. Yacoub, A.; Park, M.A.; Gupta, P.; Rahmani, M.; Zhang, G.; Hamed, H.; Hanna, D.; Sarkar, D.; Lebedeva, I.V.; Emdad, L.; Sauane, M.; Vozhilla, N.; Spiegel, S.; Koumenis, C.; Graf, M.; Curiel, D.T.; Grant, S.; Fisher, P.B.; Dent, P. Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells. Mol. Cancer Ther., 2008, 7(2), 297-313.
33. Sauane, M.; Su, Z.Z.; Dash, R.; Liu, X.; Norris, J.S.; Sarkar, D.; Lee, S.G.; Allegood, J.C.; Dent, P.; Spiegel, S.; Fisher, P.B. Ceramide plays a prominent role in MDA-7/IL-24-induced cancerspecific apoptosis. J. Cell Physiol., 2010, 222(3), 546-555.
34. Gopalan, B.; Litvak, A.; Sharma, S.; Mhashilkar, A.M.; Chada, S.; Ramesh, R. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res., 2005, 65(8), 3017-3024.
35. Ekmekcioglu, S.; Mumm, J.B.; Udtha, M.; Chada, S.; Grimm, E.A. Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24. Cytokine, 2008, 43(1), 34-44.
36. Caudell, E.G.; Mumm, J.B.; Poindexter, N.; Ekmekcioglu, S.; Mhashilkar, A.M.; Yang, X.H.; Retter, M.W.; Hill, P.; Chada, S.; Grimm, E.A. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol., 2002, 168(12), 6041-6046.
37. Kreis, S.; Munz, G.A.; Haan, S.; Heinrich, P.C.; Behrmann, I. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases. Mol. Cancer Res., 2007, 5(12), 1331-1341.
38. Sauane, M.; Gopalkrishnan, R.V.; Lebedeva, I.; Mei, M.X.; Sarkar, D.; Su, Z.Z.; Kang, D.C.; Dent, P.; Pestka, S.; Fisher, P.B. Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways. J. Cell Physiol., 2003, 196(2), 334-345.
39. Sauane, M.; Su, Z.Z.; Gupta, P.; Lebedeva, I.V.; Dent, P.; Sarkar, D.; Fisher, P.B. Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc. Natl. Acad. Sci. U.S.A., 2008, 105(28), 9763-9768.
40. Otkjaer, K.; Holtmann, H.; Kragstrup, T.W.; Paludan, S.R.; Johansen, C.; Gaestel, M.; Kragballe, K.; Iversen, L. The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA. PLoS One, 2010, 5(1), e8671.
41. Otkjaer, K.; Kragballe, K.; Johansen, C.; Funding, A.T.; Just, H.; Jensen, U.B.; Sorensen, L.G.; Norby, P.L.; Clausen, J.T.; Iversen, L. IL-20 gene expression is induced by IL-1beta through mitogenactivated protein kinase and NF-kappaB-dependent mechanisms. J. Invest. Dermatol., 2007, 127(6), 1326-1336.
42. Poindexter, N.J.; Walch, E.T.; Chada, S.; Grimm, E.A. Cytokine induction of interleukin-24 in human peripheral blood mononuclear cells. J. Leukoc Biol., 2005, 78(3), 745-752.
43. Madireddi, M.T.; Dent, P.; Fisher, P.B. Regulation of mda-7 gene expression during human melanoma differentiation. Oncogene, 2000, 19(10), 1362-1368.
44. Dean, J.L.; Sully, G.; Clark, A.R.; Saklatvala, J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal., 2004, 16(10), 1113-1121.
45. Johansen, C.; Kragballe, K.; Westergaard, M.; Henningsen, J.; Kristiansen, K.; Iversen, L. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br. J. Dermatol., 2005, 152(1), 37-42.
46. Chan, J.R.; Blumenschein, W.; Murphy, E.; Diveu, C.; Wiekowski, M.; Abbondanzo, S.; Lucian, L.; Geissler, R.; Brodie, S.; Kimball, A.B.; Gorman, D.M.; Smith, K.; de Waal Malefyt, R.; Kastelein, R.A.; McClanahan, T.K.; Bowman, E.P. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med., 2006, 203(12), 2577-2587.
47. Romer, J.; Hasselager, E.; Norby, P.L.; Steiniche, T.; Thorn Clausen, J.; Kragballe, K. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J. Invest. Dermatol., 2003, 121(6), 1306-1311.
48. Andoh, A.; Shioya, M.; Nishida, A.; Bamba, S.; Tsujikawa, T.; Kim-Mitsuyama, S.; Fujiyama, Y. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. J. Immunol., 2009, 183(1), 687-695.
49. Sainz-Perez, A.; Gary-Gouy, H.; Portier, A.; Davi, F.; Merle-Beral, H.; Galanaud, P.; Dalloul, A. High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia. Leukemia, 2006, 20(3), 498-504.
50. Aguirre-Ghiso, J.A.; Estrada, Y.; Liu, D.; Ossowski, L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res., 2003, 63(7), 1684-1695.
51. Aguirre-Ghiso, J.A.; Liu, D.; Mignatti, A.; Kovalski, K.; Ossowski, L. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol. Biol. Cell, 2001, 12(4), 863-879.
52. Sainz-Perez, A.; Gary-Gouy, H.; Gaudin, F.; Maarof, G.; Marfaing-Koka, A.; de Revel, T.; Dalloul, A. IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression. J. Immunol., 2008, 181(9), 6051-6060.
53. Ekmekcioglu, S.; Ellerhorst, J.; Mhashilkar, A.M.; Sahin, A.A.; Read, C.M.; Prieto, V.G.; Chada, S.; Grimm, E.A. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int. J. Cancer, 2001, 94(1), 54-59.
54. Ellerhorst, J.A.; Prieto, V.G.; Ekmekcioglu, S.; Broemeling, L.; Yekell, S.; Chada, S.; Grimm, E.A. Loss of MDA-7 expression with progression of melanoma. J. Clin. Oncol., 2002, 20(4), 1069-1074.
55. Zdanov, A. Structural features of the interleukin-10 family of cytokines. Curr. Pharm. Des., 2004, 10(31), 3873-3884.
56. Zdanov, A. Structural studies of the interleukin-19 subfamily of cytokines. Vitam Horm, 2006, 74 61-76.
57. Renauld, J.C. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol., 2003, 3(8), 667-676.
58. Commins, S.; Steinke, J.W.; Borish, L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J. Allergy Clin. Immunol., 2008, 121(5), 1108-1111.
59. Pestka, S.; Krause, C.D.; Walter, M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev., 2004, 202 8-32.
60. Sabat, R.; Sterry, W.; Philipp, S.; Wolk, K. Three decades of psoriasis research: where has it led us? Clin. Dermatol., 2007, 25(6), 504-509.
61. Blumberg, H.; Conklin, D.; Xu, W.F.; Grossmann, A.; Brender, T.; Carollo, S.; Eagan, M.; Foster, D.; Haldeman, B.A.; Hammond, A.; Haugen, H.; Jelinek, L.; Kelly, J.D.; Madden, K.; Maurer, M.F.; Parrish-Novak, J.; Prunkard, D.; Sexson, S.; Sprecher, C.; Waggie, K.; West, J.; Whitmore, T.E.; Yao, L.; Kuechle, M.K.; Dale, B.A.; Chandrasekher, Y.A. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell, 2001, 104(1), 9-19.
62. Otkjaer, K.; Kragballe, K.; Funding, A.T.; Clausen, J.T.; Noerby, P.L.; Steiniche, T.; Iversen, L. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br. J. Dermatol., 2005, 153(5), 911-918.
63. Kunz, S.; Wolk, K.; Witte, E.; Witte, K.; Doecke, W.D.; Volk, H.D.; Sterry, W.; Asadullah, K.; Sabat, R. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp. Dermatol., 2006, 15(12), 991-1004.
64. Wolk, K.; Kunz, S.; Asadullah, K.; Sabat, R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol., 2002, 168(11), 5397-5402.
65. Kragstrup, T.W.; Otkjaer, K.; Holm, C.; Jorgensen, A.; Hokland, M.; Iversen, L.; Deleuran, B. The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine, 2008, 41(1), 16-23.
66. Wang, M.; Liang, P. Interleukin-24 and its receptors. Immunology, 2005, 114(2), 166-170.
67. Wolk, K.; Witte, K.; Witte, E.; Proesch, S.; Schulze-Tanzil, G.; Nasilowska, K.; Thilo, J.; Asadullah, K.; Sterry, W.; Volk, H.D.; Sabat, R. Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J. Leukoc. Biol., 2008, 83(5), 1181-1193.
68. Wahl, C.; Muller, W.; Leithauser, F.; Adler, G.; Oswald, F.; Reimann, J.; Schirmbeck, R.; Seier, A.; Weiss, J.M.; Prochnow, B.; Wegenka, U.M. IL-20 receptor 2 signaling down-regulates antigenspecific T cell responses. J. Immunol., 2009, 182(2), 802-810.
69. Maarof, G.; Bouchet-Delbos, L.; Gary-Gouy, H.; Durand-Gasselin, I.; Krzysiek, R.; Dalloul, A. Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells. Blood, 2010, 115(9), 1718-1726.
70. Diehl, S.A.; Schmidlin, H.; Nagasawa, M.; van Haren, S.D.; Kwakkenbos, M.J.; Yasuda, E.; Beaumont, T.; Scheeren, F.A.; Spits, H. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol., 2008, 180(7), 4805-4815.
71. Sa, S.M.; Valdez, P.A.; Wu, J.; Jung, K.; Zhong, F.; Hall, L.; Kasman, I.; Winer, J.; Modrusan, Z.; Danilenko, D.M.; Ouyang, W. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol., 2007, 178(4), 2229-2240.
72. Griffiths, C.E.; Barker, J.N. Pathogenesis and clinical features of psoriasis. Lancet, 2007, 370(9583), 263-271.
73. Tohyama, M.; Hanakawa, Y.; Shirakata, Y.; Dai, X.; Yang, L.; Hirakawa, S.; Tokumaru, S.; Okazaki, H.; Sayama, K.; Hashimoto, K. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression. Eur. J. Immunol., 2009, 39(10), 2779-2788.
74. Boniface, K.; Guignouard, E.; Pedretti, N.; Garcia, M.; Delwail, A.; Bernard, F.X.; Nau, F.; Guillet, G.; Dagregorio, G.; Yssel, H.; Lecron, J.C.; Morel, F. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin. Exp. Immunol., 2007, 150(3), 407-415.
75. Wolk, K.; Witte, E.; Warszawska, K.; Schulze-Tanzil, G.; Witte, K.; Philipp, S.; Kunz, S.; Docke, W.D.; Asadullah, K.; Volk, H.D.; Sterry, W.; Sabat, R. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur. J. Immunol., 2009, 39(12), 3570-3581.
76. Wolk, K.; Witte, E.; Wallace, E.; Docke, W.D.; Kunz, S.; Asadullah, K.; Volk, H.D.; Sterry, W.; Sabat, R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol., 2006, 36(5), 1309-1323.
77. Wolk, K.; Haugen, H.S.; Xu, W.; Witte, E.; Waggie, K.; Anderson, M.; Vom Baur, E.; Witte, K.; Warszawska, K.; Philipp, S.; Johnson-Leger, C.; Volk, H.D.; Sterry, W.; Sabat, R. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J. Mol. Med., 2009, 87(5), 523-536.
78. He, M.; Liang, P. IL-24 Transgenic mice: In vivo Evidence of Overlapping functions for IL-20, IL-22, and IL-24 in the epidermis. J. Immunol., 2010, 184(4), 1793-1798.
79. Sano, S.; Chan, K.S.; Carbajal, S.; Clifford, J.; Peavey, M.; Kiguchi, K.; Itami, S.; Nickoloff, B.J.; DiGiovanni, J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med., 2005, 11(1), 43-49.
80. Soo, C.; Shaw, W.W.; Freymiller, E.; Longaker, M.T.; Bertolami, C.N.; Chiu, R.; Tieu, A.; Ting, K. Cutaneous rat wounds express c49a, a novel gene with homology to the human melanoma differentiation associated gene, mda-7. J. Cell Biochem., 1999, 74(1), 1-10.
81. Zheng, M.; Bocangel, D.; Doneske, B.; Mhashilkar, A.; Ramesh, R.; Hunt, K.K.; Ekmekcioglu, S.; Sutton, R.B.; Poindexter, N.; Grimm, E.A.; Chada, S. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10. Cancer Immunol. Immunother., 2007, 56(2), 205-215.
82. Zheng, M.; Bocangel, D.; Ramesh, R.; Ekmekcioglu, S.; Poindexter, N.; Grimm, E.A.; Chada, S. Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells. Mol. Cancer Ther., 2008, 7(12), 3842-3851.